Your browser doesn't support javascript.
loading
Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized study.
Tsuru, Tomomi; Tanaka, Yoshiya; Kishimoto, Mitsumasa; Saito, Kazuyoshi; Yoshizawa, Seiji; Takasaki, Yoshinari; Miyamura, Tomoya; Niiro, Hiroaki; Morimoto, Shinji; Yamamoto, Junichi; Lledo-Garcia, Rocio; Shao, Jing; Tatematsu, Shuichiro; Togo, Osamu; Koike, Takao.
Afiliação
  • Tsuru T; a PS Clinic , Fukuoka , Japan .
  • Tanaka Y; b The First Department of Internal Medicine , School of Medicine, University of Occupational and Environmental Health , Kitakyushu , Japan .
  • Kishimoto M; c Immuno-Rheumatology Center, St Luke's International Hospital , Tokyo , Japan .
  • Saito K; b The First Department of Internal Medicine , School of Medicine, University of Occupational and Environmental Health , Kitakyushu , Japan .
  • Yoshizawa S; d Department of Rheumatology , Hamanomachi Hospital , Fukuoka , Japan .
  • Takasaki Y; e Department of Internal Medicine and Rheumatology , School of Medicine, Juntendo University , Tokyo , Japan .
  • Miyamura T; f Department of Internal Medicine and Rheumatology , Clinical Research Institute, National Hospital Organization Kyushu Medical Center , Fukuoka , Japan .
  • Niiro H; g Clinical Education Center, Kyushu University Hospital , Fukuoka , Japan .
  • Morimoto S; h Department of Internal Medicine and Rheumatology , Juntendo University Urayasu Hospital , Chiba , Japan .
  • Yamamoto J; i UCB Pharma , Tokyo , Japan .
  • Lledo-Garcia R; j UCB Pharma , Slough , UK .
  • Shao J; k UCB Pharma , Shanghai , P.R. China , and.
  • Tatematsu S; i UCB Pharma , Tokyo , Japan .
  • Togo O; i UCB Pharma , Tokyo , Japan .
  • Koike T; l NTT Sapporo Medical Center , Hokkaido , Japan.
Mod Rheumatol ; 26(1): 87-93, 2016.
Article em En | MEDLINE | ID: mdl-26382733

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Imunossupressores / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Rheumatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Imunossupressores / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Rheumatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão